In a new study published in Nature’s Digital Medicine journal, WHOOP researchers have introduced a new digital biomarker for monitoring menstrual cycles through wearable technology. The study, analyzing over 45,000 menstrual cycles from 11,590 participants, represents one of the largest investigations into cardiovascular changes across menstrual cycles using wearable technology. The research team developed a novel metric called “cardiovascular amplitude” that measures…
Apricity, a virtual fertility clinic in the UK, has announced it will cease all operations effective January 1, 2025. The closure affects all services, including appointments, consultations, tests, and treatments. The announcement comes after four years of operation since the company’s launch in 2018. In response to the closure, Apricity is working with partner IVF clinics to ensure treatment continuity for current…
Gameto has announced the world’s first live birth using Fertilo, a new technology that matures eggs outside the body. The birth, which took place at Santa Isabel Clinic in Lima, Peru, represents a significant advancement in fertility treatment by eliminating approximately 80% of hormone injections typically required in conventional IVF. “We are delighted to celebrate the world’s first live birth conceived using…
Ultrahuman has announced the launch of its Cycle & Ovulation PowerPlug, a new fertility tracking feature available at no cost to Ring AIR users. The technology integrates multiple biomarkers including skin temperature, resting heart rate, and heart rate variability to track ovulation. “Most fertility tracking today is either inconvenient, expensive, or both. Women often have to use two apps, pay for two…
A new fertility treatment is showing encouraging results for couples struggling to conceive. Femasys has published results from its clinical trial of FemaSeed, a new approach to artificial insemination, in the Journal of Gynecology & Reproductive Medicine. “We are grateful for the renowned investigators from leading academic medical centers and private practices that participated in this landmark trial,” stated Kathy Lee-Sepsick, CEO…
Astorg, a pan-European private equity firm, has announced the completion of two simultaneous transactions: the take-private acquisition of Hamilton Thorne and the purchase of Cook Medical‘s Reproductive Health business (Cook Medical RH). Following these transactions, Hamilton Thorne has been delisted from the Toronto Stock Exchange. The combined entity will serve customers in over 115 countries, providing fertility clinics and IVF laboratories with…
Stork Club, a reproductive health enterprise benefits provider, has introduced Condition-Based Care Pathways, a new program that creates personalized care plans based on members’ reproductive goals, medical conditions, and chronic health needs. The program, available through Stork Club’s digital platform, aims to improve clinical outcomes while reducing healthcare costs for employers and employees. The new system addresses over 40 health conditions that…
Fellow Health has published results showing 82% compliance rates with their mail-in postvasectomy semen analysis (PVSA) kits, significantly outperforming traditional testing methods. The study, published in the Journal of Urology, demonstrates a major advancement in addressing a persistent challenge in reproductive healthcare. The findings are particularly significant given that approximately half a million vasectomies are performed annually in the United States. While…
